Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL5067989

CCCC[N+](CCCC)(CCCC)CCCC.[S-]c1ccccc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.52
SLC22A2 O15244 1/20 0.46
DNM1 Q05193 4/20 0.44
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPK1 P28482 1/20 0.43
ALDH1A1 P00352 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HTT P42858 2/20 0.42
KCNH2 Q12809 2/20 0.40
MLNR O43193 1/20 0.40
NR1I2 O75469 1/20 0.40
ESR1 P03372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL2976678 0.83 SLC22A1 (0.52) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL5270023 0.81 SLC22A1 (0.80) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL28223332 0.81 SLC22A1 (0.80) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL11246970 0.80 SLC22A1 (0.55) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL3296432 0.79 SLC22A1 (0.60) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL887137 0.78 SLC22A1 (0.52) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL623145 0.78 SLC22A1 (0.52) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL1724097 0.78 SLC22A1 (0.52) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL15453961 0.78 SLC22A1 (0.52) SLC22A1SLC22A2DNM1TP53SMN1; SMN2
Tetrabuthylammonium SCHEMBL28976384 0.78 SLC22A1 (0.52) SLC22A1SLC22A2DNM1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115010836-A Electrochromatic polymer, nano particles and device 吉林大学 2022-09-06 CN claimed
WO-2024171769-A1 METHOD FOR PRODUCING ALKYLATED COMPOUND 国立大学法人 東京大学 2024-08-22 WO disclosed
CN-115010836-B Electrochromic polymer, nano particle and device 吉林大学 2023-09-08 CN disclosed
US-8754138-B2 Polymers obtained from monomers allowing a sequential polymerization, and their use for preparing ionic conductors HYDRO-QUEBEC (CA) 2014-06-17 US disclosed
US-20130277599-A1 POLYMERS OBTAINED FROM MONOMERS ALLOWING A SEQUENTIAL POLYMERIZATION, AND THEIR USE FOR PREPARING IONIC CONDUCTORS HYDRO-QUEBEC (CA) 2013-10-24 US disclosed
US-8512899-B2 Lithium batteries; polyethers from monomers having acrylic or vinyl ethylene double bonds or perfluorosulfonate at one end of the compound and a glycidyl, dioxolyl or dioxyl group at the other; controllable molecular weight range and crosslinking density; dissolving ionic compounds; solid electrolytes HYDRO-QUEBEC (CA) 2013-08-20 US disclosed
US-20080213661-A1 Polymers Obtained From Monomers Allowing A Sequential Polymerization, And Their Use For Preparing Ionic Conductors HYDRO-QUEBEC (CA) 2008-09-04 US disclosed
US-20040220348-A1 Polymers obtained from monomers allowing a sequential polymerization, and their use for preparing ionic conductors MICHOT CHRISTOPHE (FR) 2004-11-04 US disclosed
US-20030125437-A1 Polymers obtained from monomers allowing a sequential polymerization, and their use for preparing ionic conductors MICHOT CHRISTOPHE (FR) 2003-07-03 US disclosed
US-6492449-B2 POLYMERS OBTAINED BY ANIONIC INITIATION AND BEARING FUNCTIONS THAT CAN BE ACTIVATED BY CATIONIC INITIATIONS THAT ARE NOT REACTIVE IN THE PRESENCE OF ANIONIC POLYMERIZATION INITIATORS. HYDRO-QUEBEC (CA) 2002-12-10 US disclosed
US-20020128364-A1 POLYMERS OBTAINED FROM MONOMERS ALLOWING A SEQUENTIAL POLYMERIZATION, AND THEIR USE FOR PREPARING IONIC CONDUCTORS HYDRO-QUEBEC (CA) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130277599-A1 POLYMERS OBTAINED FROM MONOMERS ALLOWING A SEQUENTIAL POLYMERIZATION, AND THEIR USE FOR PREPARING IONIC CONDUCTORS KCNN4, PUF60, HCN4 SLC22A1 2857/4885SLC22A2 2544/4885DNM1 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.